Filtered By:
Specialty: Endocrinology
Therapy: Dialysis
This page shows you your search results in order of relevance. This is page number 2.
Order by Relevance | Date
Total 18 results found since Jan 2013.
Association of renal arteriosclerosis and hypertension with renal and cardiovascular outcomes in Japanese type 2 diabetic patients with diabetic nephropathy
ConclusionsRenal AS was associated with increasing risks for renal composite events and cardiovascular events in both normal ‐range BP and HT. The risks of renal composite events and cardiovascular events were the highest in both renal AS and HT.This article is protected by copyright. All rights reserved.
Source: Journal of Diabetes Investigation - December 5, 2018 Category: Endocrinology Authors: Miho Shimizu,
Kengo Furuichi,
Tadashi Toyama,
Tomoaki Funamoto,
Shinji Kitajima,
Akinori Hara,
Yasunori Iwata,
Norihiko Sakai,
Toshinari Takamura,
Kiyoki Kitagawa,
Mitsuhiro Yoshimura,
Shuichi Kaneko,
Hitoshi Yokoyama,
Takashi Wada,
Kanazawa Tags: Original Article Source Type: research
Development and Internal Validation of a Discrete Event Simulation Model of Diabetic Kidney Disease Using CREDENCE Trial Data
ConclusionCREDEM-DKD is an important new tool in the evaluation of treatment interventions in the DKD population.Trial RegistrationClinicalTrials.gov identifier, NCT02065791.
Source: Diabetes Therapy - September 14, 2020 Category: Endocrinology Source Type: research
Cost-Effectiveness of Canagliflozin Added to Standard of Care for Treating Diabetic Kidney Disease (DKD) in Patients with Type 2 Diabetes Mellitus (T2DM) in England: Estimates Using the CREDEM-DKD Model
ConclusionModel results suggest that adding canagliflozin 100 mg to SoC can improve patient outcomes while reducing overall net costs from the NHS perspective in England.Trial RegistrationClinicalTrials.gov identifier, NCT02065791.
Source: Diabetes Therapy - December 2, 2020 Category: Endocrinology Source Type: research
